Winnie Weng

A Quantitative Framework to Evaluate Proarrhythmic Risk in a First‐in‐Human Study to Support Waiver of a Thorough QT Study

C. Garnett, S. Ramanathan, J. Lin, 2015, Clinical pharmacology and therapeutics.